EN IT

Recursion Pharmaceuticals: sell signal holds but confirmation week pushes back

Sell signal in week 2 for Recursion Pharmaceuticals, but the confirmation week closed bullish. IQS at 56, intermediate bearish structure, trading not recommended: discipline points to exiting the position.

Sell signal in observation — week 2
Recursion Pharmaceuticals: sell signal holds but confirmation week pushes back
June 05, 2026
Sell signal in observation — week 2
In Summary
Recursion Pharmaceuticals is in week 2 of a sell signal, ranking 76th out of 96 in its category. The confirmation week, however, closed bullish — a caution signal the discipline translates into an exit from the position. Trading is flagged as not recommended, and on the daily chart a double bottom in the 2.8 area is forming with an 18% intermediate rebound.
Sell signal in observation ·2nd week from start ·US stocks ·T2
IQS Phase
56
ordinary
Signal Strength
11
indecisive week
Sizing
MINIMUM
Ranking
#76 / 96
US stocks sell signals
Trade P&L %
-10.13%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn